Doctor profile · Federal record
Dr. AUDRA ADKINSON, APRN
Family Nurse Practitioner (CMS: NURSE PRACTITIONER) · WINTER HAVEN, FL
- NPI 1801460100
- Accepts Medicare
- 5 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
200 AVENUE F NE
WINTER HAVEN, FL 338814131
(863) 293-1191
Credentials & registration
- NPI registered
- May 2021 — 5 yrs on file
- Profile last updated
- November 20, 2025
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Florida #APRN11013065
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801460100. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
330
Distinct HCPCS
8
Medicare allowed
$3,371
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
36415 |
Insertion of needle into vein for collection of blood sample | 63 | 44 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 60 | 42 | $8 | |
83540 |
Iron level | 41 | 34 | $6 | |
80053 |
Blood test, comprehensive group of blood chemicals | 40 | 35 | $10 | |
82728 |
Ferritin (blood protein) level | 38 | 32 | $13 | |
84466 |
Transferrin (iron binding protein) level | 38 | 32 | $13 | |
82746 |
Folic acid level, serum | 27 | 25 | $14 | |
82607 |
Cyanocobalamin (vitamin b-12) level | 23 | 22 | $15 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 45. This provider delivers 7.3× the peer median.Open Payments
Industry payments received
All-time total
$780
Transactions
33
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $119.69 | |
| Gilead Sciences, Inc. | 4 | $99.26 | |
| PFIZER INC. | 4 | $92.78 | |
| Daiichi Sankyo Inc. | 3 | $71.21 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58.21 | |
| Merck Sharp & Dohme LLC | 2 | $48.67 | |
| Aveo Pharmaceuticals, Inc. | 2 | $47.85 | |
| TAIHO ONCOLOGY, INC. | 2 | $43.33 | |
| Incyte Corporation | 2 | $42.20 | |
| Janssen Biotech, Inc. | 2 | $40.89 | |
| Lilly USA, LLC | 1 | $28.51 | |
| Pharmacosmos Therapeutics Inc. | 1 | $24.38 | |
| GlaxoSmithKline, LLC. | 1 | $21.80 | |
| ABBVIE INC. | 1 | $21.06 | |
| Boston Scientific Corporation | 1 | $19.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
294
Patients
75
Total drug cost
$42,596
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 81 | 28 | $2,419 |
| Hydroxyurea | Generic | 67 | 20 | $1,947 |
| Tamoxifen Citrate | Generic | 44 | 13 | $1,244 |
| Eliquis (Apixaban) | Brand | 38 | 14 | $33,087 |
| Letrozole | Generic | 29 | 0 | $319 |
| Acyclovir | Generic | 12 | 0 | $165 |
| Anagrelide Hcl | Generic | 12 | 0 | $1,646 |
| Exemestane | Generic | 11 | 0 | $1,767 |